ProMIS Neurosciences Inc. SEC filings PMN
ProMIS Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 6, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 3 | Initial insider ownership | Oct 6, 2026 | Oct 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 7, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 28, 2026 | Jul 28, 2026 |
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 20, 2026 | May 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| 4 | Insider transaction | Apr 23, 2026 | Apr 22, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | May 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 7, 2026 | — |
| EFFECT | Filing | Apr 2, 2026 | — |
| CORRESP | Letter to the SEC | Mar 31, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 26, 2026 | — |
| S-3 | Shelf registration | Mar 25, 2026 | — |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| CORRESP | Letter to the SEC | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2026 | — |
| S-3 | Shelf registration | Mar 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Feb 25, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 6, 2026 | — |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 5, 2026 | — |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 2, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 19, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 29, 2025 | — |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 3 | Initial insider ownership | Oct 24, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 24, 2025 | Oct 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 23, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 15, 2025 | — |
| 4 | Insider transaction | Oct 6, 2025 | Oct 3, 2025 |
| DEFA14A | Additional proxy material | Oct 3, 2025 | — |
| DEF 14A | Proxy statement | Oct 3, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Sep 30, 2025 | Oct 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 23, 2025 | Nov 17, 2025 |
| EFFECT | Filing | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| 4 | Insider transaction | Sep 8, 2025 | Jul 25, 2025 |
| UPLOAD | Letter from the SEC | Sep 8, 2025 | — |
| S-3 | Shelf registration | Sep 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| 8-K |
Current report
Material agreement
|
Aug 19, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 3 | Initial insider ownership | Aug 14, 2025 | Jul 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4/A | Ownership document | Aug 14, 2025 | Jul 25, 2025 |
| 4/A | Ownership document | Aug 14, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Mar 13, 2025 |
| S-8 | Employee stock plan registration | Aug 13, 2025 | — |
| S-3 | Shelf registration | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2025 | — |
| 3 | Initial insider ownership | Aug 4, 2025 | Jul 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2025 | — |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 22, 2025 | Jul 22, 2025 |
| 424B5 | Prospectus supplement | Jul 22, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 12, 2025 |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 8, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 5, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 24, 2024 | Oct 23, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 16, 2024 | — |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 18, 2024 | Sep 16, 2024 |
| DEFA14A | Additional proxy material | Sep 9, 2024 | — |
| DEF 14A | Proxy statement | Sep 9, 2024 | Oct 23, 2024 |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| S-3 | Shelf registration | Aug 29, 2024 | — |
| PRE 14A | Preliminary proxy statement | Aug 29, 2024 | Oct 23, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 5, 2024 | — |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Other events
|
Jul 29, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2024 | Apr 30, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 13, 2024 |
| 424B5 | Prospectus supplement | Apr 1, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 5, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 5, 2024 | Jan 5, 2024 |
| 424B5 | Prospectus supplement | Jan 5, 2024 | — |
| 4 | Insider transaction | Jan 5, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 3, 2024 | Dec 30, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 2, 2024 | — |
| 4 | Insider transaction | Jan 2, 2024 | Dec 4, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 27, 2023 | — |
| 3 | Initial insider ownership | Dec 27, 2023 | Dec 25, 2023 |
| 3 | Initial insider ownership | Dec 27, 2023 | Dec 25, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto, Ontario, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1374339
- Former names
- AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.